Find clinical trials for Non-Small-Cell Lung Cancer in Pittsburgh, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Pittsburgh, PA, USA:
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Natrona Heights, Pennsylvania, United States and 71 other locations
3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous NSCL...
Phase 1
Pittsburgh, Pennsylvania, United States and 36 other locations
participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC)....
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 10 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Pittsburgh, Pennsylvania, United States and 230 other locations
to determine the efficacy and safety of durvalumab and/or novel oncology therapies, with or without chemotherapy, for first-line Stage IV Non...
Phase 1
Pittsburgh, Pennsylvania, United States and 40 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Pittsburgh, Pennsylvania, United States and 254 other locations
alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...
Phase 3
Pittsburgh, Pennsylvania, United States and 152 other locations
CLN-081-001 is a Phase 1/2, open label, multi-center study of CLN-081 in patients with non-small cell lung cancer...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 63 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Pittsburgh, Pennsylvania, United States and 95 other locations
the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated NSCLC tumors...
Phase 2
Pittsburgh, Pennsylvania, United States and 37 other locations
Clinical trials
Research sites
Resources
Legal